Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000628

Drug Information
NameFluconazole    
Synonymsnchembio.100-comp3; Triflucan; 86386-73-4; CCRIS 7211; DivK1c_001030; BRD-K05977355-001-02-6; Fuconal; ct Arzneimittel Brand of Fluconazole; UK49858; SMR000471882; UK 49858; KBio2_007270; FCZ; Diflazon; TL8005609; betapharm Brand of Fluconazole; I06-0069; Forcan; Loitin; KBioGR_000360; 2-(2,4-Difluoro-phenyl)-1,3-bis-[1,2,4]triazol-1-yl-propan-2-ol; Fluconazol von ct; 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol; SPECTRUM1503975; AC-428; Vita Brand of Fluconazole; Bio-0041; 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL; Fluconazole (JAN/USAN/INN); NINDS_001030; HSDB 7420; FLCZ; Zoltec; Fluconazole & MC-510,011; Fluconazol-Isis; Dimycon; DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER; Flucytosine & Nyotran; KS-1059; D015725; STK619301; XMP.391 & Fluconazole; C13H12F2N6O; S1331_Selleck; NCGC00095089-01; TPF; Fluconazole in dextrose 5% in plastic container; DIFLUCAN IN SODIUM CHLORIDE 0.9%; CHEBI:46081; Flukezol; Elazor; MLS001165780; nchembio.65-comp15; Fluconazolum [Latin]; Biocanol; Oxifungol; Apo Fluconazole; Mutum; MLS001195645; Flunizol; Lesvi Brand of Fluconazole; Fluconazole & Bovine Lactoferrin; Spectrum2_001607; Fluzone; MolPort-000-883-859; Beagyne; Flucazol; ct-Arzneimittel Brand of Fluconazole; IDI1_001030; D00322; HMS1922O10; Fluconazol AL; SPBio_001613; Apo-Fluconazole; KBioSS_002134; Apotex Brand of Fluconazole; HMS2090I20; AC1L1FRQ; Effik Brand of Fluconazole; Lavisa; Baten; 2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol; Zonal; Pritenzol; Chemia Brand of Fluconazole; SAT Brand of Fluconazole; fluconazole; CID3365; Lichtenstein Brand of Fluconazole; Afungil; XMP.366 & Fluconazole; Flucostat; Alpharma Brand of Fluconazole; NCGC00095089-02; Stada Brand of Fluconazole; AC1Q77FV; CPD000471882; Silanes Brand of Fluconazole; UK-49858; DB00196; Fluconazol [Spanish]; Fluconazol ratiopharm; MLS001066394; SAM002589905; Fluconazol-ratiopharm; NCGC00095089-04; HMS503M21; Flunazul; Fluconazol AbZ; GL663142 & Fluconazole; KBio2_004702; KBio2_002134; Fluconazole [USAN:INN:BAN:JAN]; Fluconazolum; XMP.284 & Fluconazole; Diflucan (TN); KBio3_003009; Spectrum4_000090; Fluconazole in sodium chloride 0.9%; Flucytosine & Nyotran(Liposomal Nystatin); Diflucan, Trican, Alfumet, Fluconazole; Aliud Brand of Fluconazole; 2,4-difluoro-,1-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol; Spectrum5_001277; CHEMBL106; Alflucoz; DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER; Zemyc; 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol; Fluconazole in sodium chloride 0.9% in plastic container; MolPort-002-885-825; Fluconazole & Human recombinant granulocyte colony stimulating factor; ZINC00004009; Diflucan; UNII-8VZV102JFY; Fluconazole in combination with MGCD290; F0677; ratiopharm Brand of Fluconazole; Armstrong Brand of Fluconazole; 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol; Solacap; Canzol; Mack Brand of Fluconazole; AKOS000280854; Cryptal; Syscan; Spectrum_001654; DRG-0005; Fluc Hexal; Fluconazol; HMS2093M21; BSPBio_003504; Fungata; F8929_SIGMA; Pfizer Brand of Fluconazole; Spectrum3_001912; Fluconazol Isis; Oxifugol; KBio1_001030; 2-(2,4-Difluorophenyl)-1,3-di-1H-1,2,4-triazol-1-ylpropan-2-ol; Biozolene; LS-1858; MLS001306492; Neofomiral; MLS001304713; Flucobeta; AbZ Brand of Fluconazole; Fluconazole & hGCSF; FlucoLich; NCGC00095089-05; BIDD:GT0799; Pfleger Brand of Fluconazole; Hexal Brand of Fluconazole; Fluconazol Stada    
Trade NameDiflucan; Trican; Alfumet    
CompanyPfizer    
IndicationFungal infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntifungal Agents    
CAS NumberCAS 86386-73-4
FormularC13H12F2N6O    
PubChem Compound IDCID 3365.    
PubChem Substance IDSID 192927.    
ChEBI46081;    
SuperDrug ATC IDD01AC15;    
SuperDrug CAS ID086386734;    
TargetCytochrome P450 51Inhibitor[2]
Ref 1Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia. Arch Intern Med. 2009 Aug 10;169(15):1444-5; author reply 1445. To Reference
Ref 2Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol. 2008 May 20;51(20):1953-8. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543